Markedly Reduced Azithromycin and Ceftriaxone Susceptibility in Commensal Neisseria Species in Clinical Samples From Belgian Men Who Have Sex With Men
| Errataetall: |
CommentOn: Clin Infect Dis. 2020 Mar 3;70(6):1169-1175. - PMID 31049592 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:72 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 72(2021), 2 vom: 27. Jan., Seite 363-364 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Laumen, Jolein G E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
75J73V1629 |
|---|
| Anmerkungen: |
Date Completed 28.04.2021 Date Revised 11.07.2022 published: Print CommentOn: Clin Infect Dis. 2020 Mar 3;70(6):1169-1175. - PMID 31049592 Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciaa565 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320637689 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320637689 | ||
| 003 | DE-627 | ||
| 005 | 20231225174015.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciaa565 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1068.xml |
| 035 | |a (DE-627)NLM320637689 | ||
| 035 | |a (NLM)33501961 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Laumen, Jolein G E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Markedly Reduced Azithromycin and Ceftriaxone Susceptibility in Commensal Neisseria Species in Clinical Samples From Belgian Men Who Have Sex With Men |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.04.2021 | ||
| 500 | |a Date Revised 11.07.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Clin Infect Dis. 2020 Mar 3;70(6):1169-1175. - PMID 31049592 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Cephalosporins |2 NLM | |
| 650 | 7 | |a Ceftriaxone |2 NLM | |
| 650 | 7 | |a 75J73V1629 |2 NLM | |
| 650 | 7 | |a Azithromycin |2 NLM | |
| 650 | 7 | |a 83905-01-5 |2 NLM | |
| 700 | 1 | |a Van Dijck, Christophe |e verfasserin |4 aut | |
| 700 | 1 | |a Abdellati, Said |e verfasserin |4 aut | |
| 700 | 1 | |a Manoharan-Basil, Sheeba S |e verfasserin |4 aut | |
| 700 | 1 | |a De Baetselier, Irith |e verfasserin |4 aut | |
| 700 | 1 | |a Martiny, Delphine |e verfasserin |4 aut | |
| 700 | 1 | |a Crucitti, Tania |e verfasserin |4 aut | |
| 700 | 1 | |a Kenyon, Chris |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 72(2021), 2 vom: 27. Jan., Seite 363-364 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:72 |g year:2021 |g number:2 |g day:27 |g month:01 |g pages:363-364 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciaa565 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 72 |j 2021 |e 2 |b 27 |c 01 |h 363-364 | ||